A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma
Clinical trial NCT01761266 · COMPLETED
Trial details
- NCT number
- NCT01761266
- Sponsor
- Eisai Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-11-13
- Enrollment
- 954
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.